Neuroscientific Biopharmaceuticals Ltd - Asset Resilience Ratio

Latest as of December 2025: 38.16%

Neuroscientific Biopharmaceuticals Ltd (NSB) has an Asset Resilience Ratio of 38.16% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Neuroscientific Biopharmaceuticals Ltd to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$6.36 Million

≈ $4.50 Million USD Cash + Short-term Investments

Total Assets

AU$16.66 Million

≈ $11.79 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Neuroscientific Biopharmaceuticals Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see NSB asset base.

Liquid Assets Composition Over Time

This chart breaks down Neuroscientific Biopharmaceuticals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Neuroscientific Biopharmaceuticals Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$1.11 Million	6.65%
Short-term Investments	AU$5.25 Million	31.51%
Total Liquid Assets	AU$6.36 Million	38.16%

Asset Resilience Insights

Very High Liquidity: Neuroscientific Biopharmaceuticals Ltd maintains exceptional liquid asset reserves at 38.16% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Neuroscientific Biopharmaceuticals Ltd Industry Peers by Asset Resilience Ratio

Compare Neuroscientific Biopharmaceuticals Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Vaxcyte Inc NASDAQ:PCVX	Biotechnology	41.54%
Enliven Therapeutics Inc. NASDAQ:ELVN	Biotechnology	83.46%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.12%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%

Annual Asset Resilience Ratio for Neuroscientific Biopharmaceuticals Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Neuroscientific Biopharmaceuticals Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	42.83%	AU$7.27 Million ≈ $5.14 Million	AU$16.96 Million ≈ $12.00 Million	-48.30pp
2024-06-30	91.14%	AU$4.95 Million ≈ $3.51 Million	AU$5.44 Million ≈ $3.85 Million	-1.69pp
2023-06-30	92.83%	AU$4.91 Million ≈ $3.48 Million	AU$5.29 Million ≈ $3.74 Million	-0.43pp
2022-06-30	93.26%	AU$7.22 Million ≈ $5.11 Million	AU$7.74 Million ≈ $5.47 Million	-2.25pp
2021-06-30	95.51%	AU$14.16 Million ≈ $10.02 Million	AU$14.83 Million ≈ $10.49 Million	+7.58pp
2020-06-30	87.94%	AU$3.29 Million ≈ $2.33 Million	AU$3.74 Million ≈ $2.64 Million	-2.04pp
2019-06-30	89.97%	AU$4.61 Million ≈ $3.26 Million	AU$5.12 Million ≈ $3.63 Million	--

pp = percentage points

About Neuroscientific Biopharmaceuticals Ltd

AU:NSB Australia Biotechnology

Market Cap

$14.35 Million

AU$20.29 Million AUD

Market Cap Rank

#26192 Global

#1173 in Australia

Share Price

AU$0.06

Change (1 day)

+1.67%

52-Week Range

AU$0.06 - AU$0.17

All Time High

AU$0.52